Philippines vs Syria: Cause of death, by non-communicable diseases, male
Philippines
67.2%
in 2021
Syria
67.2%
in 2021
Philippines rank
68th
Syria rank
67th
Cause of death, by non-communicable diseases, male over time
- Philippines
- Syria
How they compare
Syria currently reports 67.2% against 67.2% in Philippines, a difference of 0.0%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Syria ahead.
Philippines ranks 68th and Syria ranks 67th of 185 countries.
Across the 3 decades both report, Philippines averaged higher in 1 and Syria in 2.
Head to head by decade
| Decade | Philippines | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.6% | 75.8% | 25.2% | Syria |
| 2010s | 64.0% | 52.2% | 11.7% | Philippines |
| 2020s | 66.8% | 66.8% | 0.0% | Syria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, male, Philippines or Syria?
- Syria, at 67.2% against 67.2% in Philippines as of 2021.
- What is the difference in cause of death, by non-communicable diseases, male between Philippines and Syria?
- 0.0%, with Syria ahead.
- How many years of comparable data are there for Philippines and Syria?
- 6 years are reported by both, from 2000 to 2021.
- How do Philippines and Syria rank globally for cause of death, by non-communicable diseases, male?
- Philippines ranks 68th and Syria ranks 67th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, male (% of total male deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages due to non-communicable diseases divided by number of all male deaths ages, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.